Introduction
Ischemia/reperfusion (I/R) injury is a major cause of death and disability worldwide (Hausenloy and Yellon 2013) . The calcium overload and the generation of ROS could result in opening of mPTP, rupture of the plasma membrane and resultant cell death (Minamino 2012) . Astragaloside IV (ASI), extracted from the leguminous plants astragalus membranaceus, is a main biological activity ingredient of the astragaloside and whose molecular formula is C 41 H 68 O 14 . As a traditional Chinese medicine, ASI has been suggested to exert protective effects in multiple human disorders, including cardiovascular diseases, hepatitis, kidney disease, and skin diseases (Ren et al. 2013 ).
Among which, cardioprotective effect of ASI was investigate extensively and the potential mechanisms might be associated with regulation of energy metabolism, change of Ca 2+ -ATPase activity, dysregulations of Toll-like receptor 4/Nuclear factor-κB D r a f t 5 DNA-binding protein recombinant signal-binding protein for RBP-Jκ region, and acts on other downstream targets, such as Hes1 (Schroeter et al. 1998) . The Notch1 signaling pathway can regulate multiple cellular processes, such as cell development, cell differentiation, cell proliferation, cell apoptosis, and cell regeneration (Gude et al. 2008; Schwanbeck et al. 2011; Tremblay et al. 2013) . Hes1, which is a downstream target gene of Notch1 signaling pathway, has been demonstrated to protect the cardiomyocytes via activating the PI3K/Akt signaling pathway and modulating Notch1/Hes1-PTEN/Akt signaling ( Yu et al., 2015; Zhou et al. 2014) . And the functions of some Chinese medicines, such as Xiaotan Sanjie, salidroside, xinfeng capsule and indirubin-3'-monoxime, have been found to be relative to Notch1/Hes1 signaling pathway ( Lee et al. 2008; Wan et al. 2012; Yan et al. 2014; Zhao et al. 2014 ).
Thus, we hypothesized that the ASI protectes cardiomyocytes from A/R injury might be associated with Notch1-Hes1 signaling pathway. We used the neonate SD rat primary cardiomyocytes to establish A/R injury model in vitro. We assessed cell viability, certain biochemical parameters, the expression of Hes1 protein, ROS, ∆ψm, mPTP opening, and cell apoptosis to evaluate the cardioprotective effects of ASI.
D r a f t 6 2. Materials and methods
Reagents
ASI (purity: > 98%) was purchased from the National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China). DAPT (γ-secretase inhibitor, inhibits the Notch1 signaling pathway and Hes1 expression) was purchased from Selleckchem (S2215, USA).
Cell culture
Cardiomyocytes were isolated from 2-3 days old Sprague-Dawley (SD) rats (Medical College of Nanchang University, China) as previously described (Watkins et al. 2011 only DAPT was added to the cardiomyocytes 24 hours before A/R treatment. 
MTS assay
A colorimetric 3-(4,5-dimethylthiazol- 2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2
The determination of biochemical parameters
The culture media or cell lysate supernatants were collected. The content of malondialdehyde (MDA), and the activities of lactate dehydrogenase (LDH)，creatine phosphate kinase (CPK), glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) were detected by using certain assay kits (Jiancheng, China) following the instructions of manufacturer. The level of ∆ψm was expressed as the ratio of the red to green intensity.
Detection of intracellular ROS

Opening of the mPTP
The mitochondrias were isolated from cells with a mitochondrial/cytosolic fractionation kit (QIAGEN, Germany). The opening of the mPTP causes mitochondrial swelling after adding 200 µM CaCl 2 . The absorbance at 520 nm was continuously recorded to detect the extent of mPTP opening and the reduction in the absorbance at 520 nm/min (∆ODmin -1 ) were used to analyse the degree of mPTP opening. 
Statistical analysis
All data were expressed as mean ± SEM. Examined data were assessed by using ANOVA. P values <0.05 were considered statistically significant.
Results
ASI increased the viability of cardiomyocytes suffered A/R
The effect of ASI on the viability of neonatal rat primary caridomyocytes was examined by MTS assay. As shown in Fig 1. A, cardiomyocytes undergoing A/R D r a f t 11 decreased viability significantly (p<0.01, vs. control group). ASI+A/R groups treated with different concentrations of ASI could significantly increase the cell viability in a dose-dependent manner relative to A/R group (p<0.01), and 40 µM ASI+A/R group exhibited the highest cell viability (p<0.01). However, the cell viability decreased when ASI+A/R groups treated with a higher concentration of 80 µM, which demonstrated the higher concentration might have the doses toxic injury. The optimal concentration and precondition time was 40 µM ASI for 24 hours before A/R treatment, which was used in our subsequent experiments. In Fig. 1 .B, our data also suggested that DAPT could inhibit this effect significantly (p<0.01). Therefore, we hypothesized that the cardioprotective effects of ASI were associated with Notch1-Hes1 signaling pathway.
ASI upregulated Hes1 expression in cardiomyocytes subjected to A/R
To investigate whether Hes1 was involved in the process of ASI-induced cardioprotection and the optimal concentration of ASI, the expression of These results suggested that ASI protected cardiomyocytes from A/R-induced injury associated with up-regulation of Hes1.
ASI decreased the activities of LDH and CPK of cardiomyocytes undergoing A/R
Following A/R treatment, the activities of CPK and LDH in culture mediums were analyzed to evaluate the damages of cell membranes during A/R. There was a significant increase of the activities of LDH and CPK in A/R group compared with control group (p<0.01), yet decreased significantly in ASI+A/R group relative to A/R group (p<0.01).
Interestingly, DAPT treatment significantly increased the activities of LDH and CPK compared with ASI+A/R group (p<0.01) (Fig. 3) . in ASI+DAPT+A/R group showed that the content of MDA was decreased, while the activities of GSH-Px and SOD were increased (p<0.01, vs. AST+A/R group), which indicated that DAPT decreased oxidative stress damage and the antioxidative effect of ASI might be independent with Notch1/Hes-1 signaling pathway (Table 1) .
ASI decreased the ROS generation and oxidative stress damage induced by A/R
ASI prevented ∆ψm loss in cardiomyocytes after A/R injury
JC-1 fluorescent probe was used to determine the ∆ψm in cardiomyocytes subjected to A/R injury. The ratio of fluorescence in upper right quadrant and lower right quadrant was used to evaluate the level of ∆ψm. In the A/R group, there was a significant decrease of ∆ψm relative to control group (p<0.01) (Fig. 5) . However, ASI+A/R group significantly prevented the loss of ∆ψm (p<0.01, vs. A/R group). A decrease of ∆ψm was observed in both the ASI+DAPT+A/R and DAPT+A/R groups (p<0.01, vs. ASI+A/R group), indicating that DAPT could abolish the effect of ASI on ∆ψm.
ASI inhibited the opening of mPTP undergoing A/R
In Fig. 6 , the extent of mPTP opening was analysed by the change of absorbance at 520 nm/min (∆ODmin -1 ). ∆A520 was significantly increased in the A/R group (p<0.01, vs. control group), while it was attenuated in ASI+A/R group (p<0.01, vs. A/R group). A significant decrease in ∆A520 was observed in ASI+DAPT+A/R group (p<0.01, vs. ASI has been demonstrated the cardioprotective effects via regulating energy metabolism, Ca 2+ -ATPase activity, TLR4/NF-κB, PI3K/Akt and HIF-1α signaling pathway (Jia et al. 2014; Lu et al. 2015; Si et al. 2014; Tu et al. 2013; Xu et al. 2007 ).
However, the mechanism of ASI protection against I/R injury is not completely clear. 
